Assessing the immunogenicity risk of salmon calcitonin peptide impurities using in silico and in vitro methods
Advances in synthetic peptide synthesis have enabled rapid and cost-effective peptide drug manufacturing. For this reason, peptide drugs that were first produced using recombinant DNA (rDNA) technology are now being produced using solid- and liquid-phase peptide synthesis. While peptide synthesis ha...
Saved in:
Main Authors: | Brian J. Roberts (Author), Aimee E. Mattei (Author), Kristina E. Howard (Author), James L. Weaver (Author), Hao Liu (Author), Sandra Lelias (Author), William D. Martin (Author), Daniela Verthelyi (Author), Eric Pang (Author), Katie J. Edwards (Author), Anne S. De Groot (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Salmon Calcitonin Attenuates Some Behavioural Responses to Nicotine in Male Mice
by: Cajsa Aranäs, et al.
Published: (2021) -
Salmon Calcitonin Exerts an Antidepressant Effect by Activating Amylin Receptors
by: Jian Jiang, et al.
Published: (2022) -
Salmon calcitonin - a boon in the management of central giant cell granuloma
by: D Nivethitha Gangai, et al.
Published: (2018) -
Hypophagia induced by salmon calcitonin, but not by amylin, is partially driven by malaise and is mediated by CGRP neurons
by: Lavinia Boccia, et al.
Published: (2022) -
In silico methods for immunogenicity risk assessment and human homology screening for therapeutic antibodies
by: Aimee E. Mattei, et al.
Published: (2024)